KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Goodwill (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Goodwill for 8 consecutive years, with $119.0 million as the latest value for Q4 2025.

  • Quarterly Goodwill changed 0.0% to $119.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $119.0 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $119.0 million for FY2025, 0.0% changed from the prior year.
  • Goodwill hit $119.0 million in Q4 2025 for Adaptive Biotechnologies, roughly flat from $119.0 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $119.0 million in Q1 2021 to a low of $119.0 million in Q1 2021.
  • Historically, Goodwill has averaged $119.0 million across 5 years, with a median of $119.0 million in 2021.
  • Biggest YoY gain for Goodwill was 0.0% in 2021; the steepest drop was 0.0% in 2021.
  • Year by year, Goodwill stood at $119.0 million in 2021, then changed by 0.0% to $119.0 million in 2022, then changed by 0.0% to $119.0 million in 2023, then changed by 0.0% to $119.0 million in 2024, then changed by 0.0% to $119.0 million in 2025.
  • Business Quant data shows Goodwill for ADPT at $119.0 million in Q4 2025, $119.0 million in Q3 2025, and $119.0 million in Q2 2025.